SiftMed
Develops AI software that surfaces relevant facts from large volumes of medical records for healthcare-adjacent workflows.
Overview
SiftMed builds AI technology for reviewing large volumes of medical records, helping users identify relevant facts that may be missed in manual review. Its product is positioned for organizations that need to process complex clinical documentation at scale. The company’s differentiation centers on applying AI to medical-record analysis, where speed and accuracy can be constrained by the volume and complexity of files. SiftMed has raised $5 million in an undisclosed round announced in July 2026, representing its total disclosed funding to date.
Funding History
SiftMed lands $5 million to find the facts humans can miss in mountains of medical records
Frequently Asked Questions
- How much funding does AI Funding track for SiftMed?
- AI Funding tracks $5M for SiftMed across 1 funding round in this database.
- Who are SiftMed's investors?
- SiftMed's investors include Toronto’s Staircase Ventures.
- What does SiftMed do?
- SiftMed builds AI technology for reviewing large volumes of medical records, helping users identify relevant facts that may be missed in manual review. Its product is positioned for organizations that need to process complex clinical documentation at scale. The company’s differentiation centers on applying AI to medical-record analysis, where speed and accuracy can be constrained by the volume and complexity of files. SiftMed has raised $5 million in an undisclosed round announced in July 2026, representing its total disclosed funding to date.
- Where is SiftMed headquartered?
- SiftMed is headquartered in St. John's, Canada.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.